Skip to main content
Log in

Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to determine the utility of the peritoneal lavage cytology findings in predicting the clinical outcomes of resectable left-sided pancreatic cancer.

Methods

Peritoneal lavage samples were collected from 39 consecutive patients who underwent surgery for left-sided pancreatic cancer between January 2000 and December 2010. We analyzed the correlations between the peritoneal lavage cytology findings and the clinical outcomes.

Results

Five patients (12.8 %) had malignant cells in the cytology samples (positive cytology). This occurred more frequently in patients with vascular invasion (P = 0.008). Positive cytology was significantly associated with lower overall (P = 0.0007) and recurrent-free (P < 0.0001) survival rates. Positive cytology was an independent prognostic factor for recurrence (P = 0.022); it was closely associated with local recurrence, peritoneal recurrence and distant metastasis.

Conclusion

Surgeons should carefully consider the intraoperative diagnosis of peritoneal lavage cytology in patients with resectable left-sided pancreatic cancers, because patients with positive cytology are likely to experience recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363(9414):1049–57 (Epub 2004/03/31).

    Article  CAS  PubMed  Google Scholar 

  2. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, et al. Pancreaticoduodenectomy and palliation in pancreatic carcinoma. Gastroenterology. 1997;112(3):1046–8 (Epub 1997/03/01).

    Article  CAS  PubMed  Google Scholar 

  3. Johnson CD, Schwall G, Flechtenmacher J, Trede M. Resection for adenocarcinoma of the body and tail of the pancreas. Br J Surg. 1993;80(9):1177–9 (Epub 1993/09/01).

    Article  CAS  PubMed  Google Scholar 

  4. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1–7 (Epub 1999/07/13).

    Article  CAS  PubMed  Google Scholar 

  5. Jimenez RE, Warshaw AL, Rattner DW, Willett CG, McGrath D. Fernandez-del Castillo C. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg. 2000;135(4):409–14 (discussion 14–5. Epub 2000/04/18).

    Article  CAS  PubMed  Google Scholar 

  6. Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19(5):638–42 (Epub 2005/03/19).

    Article  CAS  PubMed  Google Scholar 

  7. Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB 3rd, Berlin JD, et al. Pancreatic adenocarcinoma. J Natl Compr Cancer Netw. 2010;8(9):972–1017 (Epub 2010/09/30).

    CAS  Google Scholar 

  8. Isaji S, Kawarada Y, Uemoto S. Classification of pancreatic cancer: comparison of Japanese and UICC classifications. Pancreas. 2004;28(3):231–4 (Epub 2004/04/16).

    Article  PubMed  Google Scholar 

  9. Eguchi H, Nagano H, Tanemura M, Takeda Y, Marubashi S, Kobayashi S, et al. Preoperative chemoradiotherapy, surgery and adjuvant therapy for resectable pancreatic cancer. Hepatogastroenterology. 2013;60(126):904–11 (Epub 2013/01/17).

    CAS  PubMed  Google Scholar 

  10. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–77 (Epub 2007/01/18).

    Article  CAS  PubMed  Google Scholar 

  11. Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual, vol. xix. 7th ed. New York: Springer; 2010. p. 718.

    Google Scholar 

  12. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM classification of malignant tumours, vol. xx. 7th ed. NJ: Wiley-Blackwell; 2010. p. 309.

    Google Scholar 

  13. Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg. 1991;161(1):26–9 (discussion 9–30. Epub 1991/01/01).

    Article  CAS  PubMed  Google Scholar 

  14. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg. 1995;82(8):1127–9 (Epub 1995/08/01).

    Article  CAS  PubMed  Google Scholar 

  15. Leach SD, Rose JA, Lowy AM, Lee JE, Charnsangavej C, Abbruzzese JL, et al. Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery. 1995;118(3):472–8 (Epub 1995/09/01).

    Article  CAS  PubMed  Google Scholar 

  16. Makary MA, Warshaw AL, Centeno BA, Willet CG, Rattner DW, Fernandez-del Castillo C. Implications of peritoneal cytology for pancreatic cancer management. Arch Surg. 1998;133(4):361–5 (Epub 1998/05/23).

    Article  CAS  PubMed  Google Scholar 

  17. Merchant NB, Conlon KC, Saigo P, Dougherty E, Brennan MF. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg. 1999;188(4):421–6 (Epub 1999/04/09).

    Article  CAS  PubMed  Google Scholar 

  18. Jimenez RE, Warshaw AL, Fernandez-Del Castillo C. Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. J Hepatobiliary Pancreat Surg. 2000;7(1):15–20 (Epub 2000/09/12).

    Article  CAS  PubMed  Google Scholar 

  19. Ferrone CR, Haas B, Tang L, Coit DG, Fong Y, Brennan MF, et al. The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg. 2006;10(10):1347–53 (Epub 2006/12/19).

    Article  PubMed  Google Scholar 

  20. Clark CJ, Traverso LW. Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer. Am J Surg. 2010;199(5):657–62 (Epub 2010/05/15).

    Article  PubMed  Google Scholar 

  21. Konishi M, Kinoshita T, Nakagohri T, Inoue K, Oda T, Takahashi S. Prognostic value of cytologic examination of peritoneal washings in pancreatic cancer. Arch Surg. 2002;137(4):475–80 (Epub 2002/04/03).

    Article  PubMed  Google Scholar 

  22. Yachida S, Fukushima N, Sakamoto M, Matsuno Y, Kosuge T, Hirohashi S. Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer. Br J Surg. 2002;89(5):573–8 (Epub 2002/04/26).

    Article  CAS  PubMed  Google Scholar 

  23. Meszoely IM, Lee JS, Watson JC, Meyers M, Wang H, Hoffman JP. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. Am Surg. 2004;70(3):208–13 (discussion 13–4. Epub 2004/04/02).

    PubMed  Google Scholar 

  24. Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, et al. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis. Ann Surg. 2007;246(2):254–8 (Epub 2007/08/02).

    Article  PubMed Central  PubMed  Google Scholar 

  25. Yoshioka R, Saiura A, Koga R, Arita J, Takemura N, Ono Y, et al. The implications of positive peritoneal lavage cytology in potentially resectable pancreatic cancer. World J Surg. 2012;36(9):2187–91 (Epub 2012/05/05).

    Article  PubMed  Google Scholar 

  26. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223(5):506–11 (discussion 11–2. Epub 1996/05/01).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Fabre JM, Houry S, Manderscheid JC, Huguier M, Baumel H. Surgery for left-sided pancreatic cancer. Br J Surg. 1996;83(8):1065–70 (Epub 1996/08/01).

    Article  CAS  PubMed  Google Scholar 

  28. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995;82(1):111–5 (Epub 1995/01/01).

    Article  CAS  PubMed  Google Scholar 

  29. Lillemoe KD, Kaushal S, Cameron JL, Sohn TA, Pitt HA, Yeo CJ. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg. 1999;229(5):693–8 (discussion 8–700. Epub 1999/05/11).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Falconi M, Mantovani W, Bettini R, Talamini G, Bassi C, Cascinu S, et al. Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? Dig Liver Dis. 2003;35(6):421–7 (Epub 2003/07/19).

    Article  CAS  PubMed  Google Scholar 

  31. Shoup M, Conlon KC, Klimstra D, Brennan MF. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg. 2003;7(8):946–52 (discussion 52. Epub 2003/12/17).

    Article  PubMed  Google Scholar 

  32. Bergenfeldt M, Moesgaard F, Burcharth F. Curative resection for left-sided pancreatic malignancy. HPB (Oxford). 2006;8(3):211–5 (Epub 2008/03/12).

    Article  Google Scholar 

  33. Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, et al. Oncological problems in pancreatic cancer surgery. World J Gastroenterol. 2006;12(28):4466–72 (Epub 2006/07/29).

    PubMed Central  PubMed  Google Scholar 

  34. Eguchi H, Ohigashi H, Takahashi H, Yano M, Motoori M, Miyashiro I, et al. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer. Surgery. 2009;146(5):888–95 (Epub 2009/09/12).

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Yoshifumi Iwagami and co-authors have no conflicts of interest to declare in association with this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroaki Nagano.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iwagami, Y., Eguchi, H., Wada, H. et al. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer. Surg Today 45, 444–450 (2015). https://doi.org/10.1007/s00595-014-0964-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-014-0964-7

Keywords

Navigation